| Date Filed | Type | Description |
| 06/15/2023 |
4
| Iannone Robert (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 22,383 options to buy
@ $14.77, valued at
$330.6k
|
|
| 06/07/2023 |
4
| Iannone Robert (EVP, Global Head of Research a) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Disposed/sold 1,311 shares
@ $129.73, valued at
$170.1k
|
|
| 05/04/2023 |
4
| Iannone Robert (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Disposed/sold 31,400 options to buy
@ $7.19, valued at
$225.8k
Disposed/sold 7,850 options to buy
@ $7.58, valued at
$59.5k
Disposed/sold 15,700 options to buy
@ $7.27, valued at
$114.1k
Disposed/sold 20,000 options to buy
@ $2.8, valued at
$56k
|
|
| 03/07/2023 |
4
| Iannone Robert (EVP, Global Head of Research a) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 12,447 shares
@ $0
Paid exercise price by delivering 2,274 shares
@ $142.78, valued at
$324.7k
|
|
| 12/13/2022 |
4
| Iannone Robert (EVP, Global Head of R&D) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 1,844 shares
@ $151.54, valued at
$279.4k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/09/2021 |
4
| Iannone Robert (EVP R&D, Chief Medical Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 741 shares
@ $164.75, valued at
$122.1k
|
|
| 03/01/2021 |
4
| Iannone Robert (EVP, Research & Development) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 8,535 shares
@ $0 |
|
| 07/02/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| Iannone Robert (EVP, Research & Development) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 943 shares
@ $120.65, valued at
$113.8k
|
|
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2020 |
4
| Iannone Robert (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 31,400 options to buy
@ $7.19, valued at
$225.8k
|
|
| 01/23/2020 |
3
| Iannone Robert (Director) has filed a Form 3 on Jounce Therapeutics, Inc. |
| 08/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2019 |
3
| Iannone Robert (EVP, Research & Development) has filed a Form 3 on Jazz Pharmaceuticals plc |
| 03/18/2019 |
4
| Iannone Robert (CHIEF MEDICAL OFFICER) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 51,230 options to buy
@ $17.94, valued at
$919.1k
Granted 25,660 options to buy
@ $17.94, valued at
$460.3k
|
|
| 09/18/2018 |
4
| Iannone Robert (Chief Medical Officer) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 15,900 options to buy
@ $22.27, valued at
$354.1k
|
|
| 04/23/2018 |
3
| Iannone Robert (See Remarks) has filed a Form 3 on IMMUNOMEDICS INC |